RecruitingNCT04300257
Swiss Sarcoma Network: Prediction Model for Patient Selection in Sarcoma Care
Studying Epithelioid sarcoma
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Kantonsspital Winterthur KSW
- Principal Investigator
- Bruno Fuchs, ProfSwissSarcomaNetwork
- Enrollment
- 600 enrolled
- Eligibility
- All sexes
- Timeline
- 2019 – 2029
Study locations (8)
- Kantonsspital Winterthur, Winterthur, Canton of Zurich, Switzerland
- SwissSarcomaNetwork, Winterthur, Canton of Zurich, Switzerland
- Ente Ospedaliero Cantonale, Bellinzona, Canton Ticino, Switzerland
- Kantonsspital Graubünden, Chur, Kanton Graubünden, Switzerland
- Luzerner Kantonsspital, Lucerne, Switzerland
- Pathologie Institut Enge, Zurich, Switzerland
- Klinik Hirslanden, Zurich, Switzerland
- Stadtspital Zürich Triemli, Zurich, Switzerland
Collaborators
Swiss Sarcoma Network
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT04300257 on ClinicalTrials.govOther trials for Epithelioid sarcoma
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE2NCT07089992A Study of Pembrolizumab in People With Ultra-Rare SarcomasMemorial Sloan Kettering Cancer Center
- RECRUITINGPHASE1, PHASE2NCT04390737Evaluate the Safety and Clinical Activity of HH2853Haihe Biopharma Co., Ltd.
- RECRUITINGNCT03099681An Observational Study on Epithelioid SarcomaItalian Sarcoma Group